AZ's Zavicefta Gains EU Positive Opinion For “Superbug” Infections

 
• By John Davis

The CHMP followed recent EMA guidance to take a flexible approach to drugs against multi-resistant pathogens when recommending approval for AstraZeneca’s latest antibacterial Zavicefta.

Lactobacillus bacteria

More from New Products

More from Scrip